A 36-year-old male with ulcerative colitis on adalimumab developed acute uveitis linked to Vogt-Koyanagi-Harada disease.
His uveitis was effectively treated with systemic corticosteroids and mycophenolate mofetil, leading to resolution of symptoms.
One year later, he was diagnosed with systemic lupus erythematosus after stopping adalimumab, indicating a potential link between the drug and severe autoimmune conditions.